Improved Contemporary Surgical Management of Insulinomas: A 25-year Experience at the Massachusetts General Hospital
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 39 of the 41 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To determine changes in the management strategy of patients with insulinomas and identify critical factors in patient outcome. BACKGROUND: Pancreatic insulinomas are rare neoplasms that are present in various ways. The optimal approach to localization, operative management, and follow-up of insulinomas is undetermined. METHODS: Sixty-one patients with a diagnosis of insulinoma requiring surgery at a tertiary care center between 1983 and 2007 were reviewed. Demographic details, mode of presentation, preoperative localization, operative procedures, and pathology data were assessed. The effect of different factors on survival was determined. RESULTS: Seven of 61 (11%) patients had a diagnosis of multiple endocrine neoplasia-type 1 (MEN-1). Multiple insulinomas were noted in 8% of cases and were more common in MEN-1 patients. The overall rate of malignancy was 8%. Confusion (67%), visual disturbances (42%), and diaphoresis (30%) were the most common presenting symptoms. Weight gain was noted in 44% of patients. The median duration of symptoms before diagnosis was 18 (1-240) months. The sensitivity of preoperative imaging of tumors before 1994 was 75%, compared with 98% after this period, which included use of endoscopic ultrasound scanning (P = 0.012). A combination of palpation and intraoperative ultrasound detected 92% of tumors. Distal pancreatectomy (40%), enucleation (34%), and pancreaticoduodenectomy (16%) were the most common procedures and pancreatic fistula occurred in 18% of patients. Three patients underwent noncurative distal pancreatectomy in the early period. The 10-year disease-specific and disease-free survival was 100% and 90% respectively. There were 5 patients with disease recurrence. Lymph node metastases (P < 0.001), lymphovascular invasion (P < 0.001), and the presence of MEN-1 (P = 0.035) were prognostically significant adverse factors in disease-free survival. Lymphovascular invasion was the only significant factor on multivariate analysis (P = 0.002). CONCLUSION: Pancreatic insulinomas can be readily localized preoperatively with modern imaging to avoid unsuccessful blind pancreatic resection. Surgical resection is associated with low morbidity and mortality and achieves long-term disease-free survival in the absence of lymphovascular invasion.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“With the combination of noninvasive and selected invasive modalities (particularly endoscopic ultrasound), most insulinomas are localized preoperatively (72, 78).”
From Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline (2009) · cites this paper as [78]
Citations
Cites
Postoperative pancreatic fistula: An international study group (ISGPF) definition
Bassi, C., Dervenis, C., Butturini, G., Fingerhut, A., Yeo, C., Izbicki, J., Neoptolemos, J., Sarr, M., Traverso, W., & Buchler, M. (2005) · Surgery · doi:10.1016/j.surg.2005.05.001 · Cited by 4,277
Functioning insulinoma—incidence, recurrence, and long-term survival of patients: a 60-year study.
SERVICE, F. J., McMAHON, M. M., O'BRIEN, P. C., & BALLARD, D. J. (1991) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)62083-7 · Cited by 883 · cited 5×
“They have a slight predilection for women and most commonly are sporadic, with less than 10% associated with multiple endocrine neoplasia-type 1 (MEN-1).(1,2) Symptoms from insulinoma are related to episodes of hypoglycemia.”
BackgroundResultInfluentialThe Gastroenteropancreatic Neuroendocrine Cell System and Its Tumors: The WHO Classification
KLÖPPEL, G., PERREN, A., & HEITZ, P. U. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1294.002 · Cited by 794
Balcom IV, J. H. (2001) · Archives of Surgery · doi:10.1001/archsurg.136.4.391 · Cited by 769
Self-citationConservation of the Spleen With Distal Pancreatectomy
Warshaw, A. L. (1988) · Archives of Surgery · doi:10.1001/archsurg.1988.01400290032004 · Cited by 614
Self-citationCARCINOMA OF THE ISLANDS OF THE PANCREAS: HYPERINSULINISM AND HYPOGLYCEMIA
WILDER, R. M., ALLAN, F. N., POWER, M. H., & ROBERTSON, H. E. (1927) · Journal of the American Medical Association · doi:10.1001/jama.1927.02690050014007 · Cited by 443
Anderson, M. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)01272-7 · Cited by 399
Hochwald, S. N., Zee, S., Conlon, K. C., Colleoni, R., Louie, O., Brennan, M. F., & Klimstra, D. S. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.10.030 · Cited by 397
Beta-islet cell tumors of the pancreas: results of a study on 1,067 cases.
STEFANINI, P., Carboni, M., Patrassi, N., & Basoli, A. (1974) · PubMed · Cited by 296
Service, F. J., Dale, A. J. D., Elveback, L. R., & JIANG, N.-S. (1976) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(25)07100-9 · Cited by 288
Research works printed but not linked: 1
- Howland, 1929, Dysinsulinism: convulsions and coma due to islet cell tumor of the pancreas with operation and cure., JAMA, 93, 647
Cited by
Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
Thakker, R. V., Newey, P. J., Walls, G. V., Bilezikian, J., Dralle, H., Ebeling, P. R., Melmed, S., Sakurai, A., Tonelli, F., & Brandi, M. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1230 · Cited by 1,477
Cryer, P. E., Axelrod, L., Grossman, A. B., Heller, S. R., Montori, V. M., Seaquist, E. R., & Service, F. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1410 · Cited by 1,277
Self-citationFrancis, G. L., Waguespack, S. G., Bauer, A. J., Angelos, P., Benvenga, S., Cerutti, J. M., Dinauer, C. A., Hamilton, J., Hay, I. D., Luster, M., et al. (2015) · Thyroid · doi:10.1089/thy.2014.0460 · Cited by 1,238
Ramage, J. K., Ahmed, A., Ardill, J., Bax, N., Breen, D. J., Caplin, M. E., Corrie, P., Davar, J., Davies, A. H., Lewington, V, et al. (2012) · Gut · doi:10.1136/gutjnl-2011-300831 · Cited by 952
Gastrointestinal Neuroendocrine Tumors: Pancreatic Endocrine Tumors
Metz, D. C., & Jensen, R. T. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.05.047 · Cited by 816
Metadata
- Authors
- Nikfarjam, M., Warshaw, A. L., Axelrod, L., Deshpande, V., Thayer, S. P., Ferrone, C. R., & Fernández-del Castillo, C.
- Affiliations
- Harvard University (US)
- Nebraska Medical Center (US)
- Corresponding author
- Nikfarjam, Mehrdad
- Warshaw, Andrew L.
- Thayer, Sarah P.
- Ferrone, Cristina R.
- Venue
- Annals of Surgery
- Published
- 2008-01
- Volume
- 247
- Issue
- 1
- Pages
- 165-172
- ISSN
- 0003-4932 (ISSN-L)
- PMC
- PMC3806046
- OpenAlex
- W1999848832
- Cited by
- 221
- References
- 41
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 10 · 2023: 9 · 2022: 11 · 2021: 11 · 2020: 13 · 2019: 9 · 2018: 6 · 2017: 18 · 2016: 8 · 2015: 15 · 2014: 18 · 2013: 19 · 2012: 22
- FWCI
- 10.39
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Annals of Surgery (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (P01CA117969)
- Topics
- Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Keywords
- insulinoma, pancreatic neuroendocrine tumors, multiple endocrine neoplasia type 1, preoperative tumor localization, endoscopic ultrasound, intraoperative ultrasound, distal pancreatectomy, pancreaticoduodenectomy, pancreatic enucleation, pancreatic fistula, lymphovascular invasion, lymph node metastasis, disease-free survival, prognostic factors, tumor recurrence, surgical resection
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Child, Female, Humans, Insulinoma, Male, Massachusetts, Middle Aged, Neoplasm Recurrence, Local, Pancreatic Neoplasms, Postoperative Complications, Prognosis, Prospective Studies, Survival Rate, Chi-Square Distribution, Proportional Hazards Models, Treatment Outcome, Statistics, Nonparametric
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Improved Contemporary Surgical Management of Insulinomas: A 25-year Experience at the Massachusetts General Hospital. https://app.cochat.ai/papers/10.1097/sla.0b013e31815792ed
- The paper
- Nikfarjam, M., Warshaw, A. L., Axelrod, L., Deshpande, V., Thayer, S. P., Ferrone, C. R., & Fernández-del Castillo, C. (2008). Improved Contemporary Surgical Management of Insulinomas: A 25-year Experience at the Massachusetts General Hospital. Annals of Surgery. https://doi.org/10.1097/sla.0b013e31815792ed
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.